# OnCo record adcytherix (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/adcytherix/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "adcytherix" ;
  schema:name "Adcytherix"@en ;
  schema:description "Adcytherix is a French company developing antibody-drug conjugates with new kinds of cell-killing drug, aimed at cancers that have stopped responding to existing conjugates. Its first medicine was being prepared for human trials in late 2025."@en ;
  schema:url <https://onco.cc/companies/adcytherix/>, <https://www.adcytherix.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.adcytherix.com/>, <https://www.biospace.com/press-releases/adcytherix-raises-eur-105m-series-a-to-accelerate-breakthrough-antibody-drug-conjugate-pipeline-with-strategic-focus-on-novel-payloads> ;
  schema:addressCountry "FR" ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/> .
